Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.
Arikayce Side Effects Center: Detailed Datasheet
Medically reviewed by Min Clinic Staff | Updated: January 2026
- Generic Name: amikacin liposome inhalation suspension
- Brand Name: Arikayce
Arikayce (Amikacin Liposome Inhalation Suspension) side effects drug center
Arikayce Side Effects Center
Arikayce (amikacin liposome inhalation suspension) is an aminoglycoside antibacterial indicated in adults who have limited or no alternative treatment options, for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen in patients who do not achieve negative sputum cultures after a minimum of 6 consecutive months of a multidrug background regimen therapy. This drug is indicated for use in a limited and specific population of patients. Common side effects of Arikayce include:
- difficulty speaking,
- cough,
- bronchospasm,